Compare RBBN & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RBBN | NAGE |
|---|---|---|
| Founded | 1997 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 671.1M | 766.4M |
| IPO Year | 2000 | N/A |
| Metric | RBBN | NAGE |
|---|---|---|
| Price | $2.95 | $6.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $6.00 | ★ $16.33 |
| AVG Volume (30 Days) | 737.2K | ★ 748.2K |
| Earning Date | 10-22-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1093.81 |
| EPS | N/A | ★ 0.23 |
| Revenue | ★ $868,592,000.00 | $124,709,000.00 |
| Revenue This Year | $5.02 | $30.37 |
| Revenue Next Year | $5.74 | $20.36 |
| P/E Ratio | ★ N/A | $27.76 |
| Revenue Growth | 7.38 | ★ 36.04 |
| 52 Week Low | $2.72 | $5.16 |
| 52 Week High | $5.38 | $14.69 |
| Indicator | RBBN | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 45.84 | 38.16 |
| Support Level | $2.73 | $6.40 |
| Resistance Level | $3.05 | $6.77 |
| Average True Range (ATR) | 0.09 | 0.22 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 67.19 | 5.33 |
Ribbon Communications Inc provides network solutions to service providers and enterprises. The company enables service providers and enterprises to modernize their communications networks and provide secure real-time communications solutions to their customers and employees. The company has two separate lines of business; the Cloud and Edge segment, and the IP Optical Networks segment. The majority of the revenue for the company is generated from its Cloud and Edge segment that provides secure and reliable software and hardware products, solutions, and services for VoIP communications, Voice Over LTE among others to service providers and enterprise customers. The company generates majority of its revenue from United States.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.